Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 15, 2024Business Wire • 02/01/24
Organon & Co (OGN) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)Seeking Alpha • 01/10/24
Organon affirms 2023 revenue and Adjusted EBITDA guidance and provides 2024 outlookBusiness Wire • 01/08/24
11 dividend stocks with high yields expected to be well supported in 2024 per strict criteriaMarket Watch • 12/27/23
High Risk, High Reward: Why 8.5%-Yielding Organon Could Be Up To 90% UndervaluedSeeking Alpha • 12/19/23
Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine MedicinesBusiness Wire • 12/18/23
Organon & Co (OGN) Piper Sandler 35th Annual Healthcare Conference (Transcript)Seeking Alpha • 11/29/23
Is This Healthcare Stock's 10% Yield a Steal of a Deal or Too Good to Be True?The Motley Fool • 11/21/23
Organon (OGN) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 11/02/23
Organon and Sempre Health Announce Collaboration on New Service to Help Eligible Patients Save Money and Stay on Their Medication as PrescribedBusiness Wire • 11/01/23
Analysts Estimate Organon (OGN) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 10/26/23
Organon To Report Third Quarter Results and Host Conference Call on November 2, 2023Business Wire • 10/19/23
Lululemon Athletica & Hubbell Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600PRNewsWire • 10/13/23
Organon Recognized on Fortune's 2023 Change the World List for Leadership in Expanding Access to Contraceptive ChoiceBusiness Wire • 09/27/23